Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
11
pubmed:dateCreated
1993-7-7
pubmed:abstractText
A "caged" analogue of the alpha-adrenergic receptor agonist phenylephrine (PE) was prepared by exploiting the 2-nitrobenzyl protecting group and using a synthetic procedure developed to permit preferential derivatization at the amino group. On isolated adult rat mesenteric arterioles, caged-PE had no measurable effects at concentrations up to 100 microM; 0.5-ms light flashes in the presence of caged-PE, however, produced marked and dose-dependent vasoconstriction. Flash-induced vasoconstrictions were blocked by the alpha-receptor antagonist phentolamine and were unaffected by the beta-receptor antagonist propranolol, indicating that the light-induced responses reflect the selective activation of alpha-adrenergic receptors. After a single flash, a large transient decrease in vessel diameter was recorded, and in most vessels, this was followed by a smaller, sustained constriction. The sustained component of the contraction was selectively eliminated when Ca2+ was removed from the bath, which suggests that different mechanisms underlie the transient and the sustained responses to PE. The responses to single flashes of varying intensities occurred with a mean latency of 460 ms, which is consistent with the intermediacy of several steps between alpha-receptor activation and contraction. We anticipate that it will be possible to extend this approach to develop caged analogues of other neurotransmitters for mechanistic and kinetic studies.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1429583, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1694411, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1705699, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1848034, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1848119, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-1848121, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2000774, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2041219, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2078315, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2469211, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2653185, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2660825, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2706267, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2903506, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-2906146, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-3033708, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-3707910, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-6086886, http://linkedlifedata.com/resource/pubmed/commentcorrection/8389474-6327971
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
90
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5199-203
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
"Caged" phenylephrine: development and application to probe the mechanism of alpha-receptor-mediated vasoconstriction.
pubmed:affiliation
Department of Molecular Biology and Pharmacology, Washington University School of Medicine, St. Louis, MO 63110.
pubmed:publicationType
Journal Article, In Vitro, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't